Baldwin Insurance Group (NASDAQ: BWIN) is set to announce its financial results for the fourth quarter of 2025 on **February 26, 2026**, after the market closes. Analysts anticipate the company will report earnings of **$0.29** per share, alongside projected revenues of **$351.75 million** for the quarter. Investors can access the latest details regarding the earnings call, scheduled for **5:00 PM ET**, on the company’s dedicated earnings summary page.
Current Stock Performance and Insider Activity
As of **Tuesday**, Baldwin Insurance Group’s stock opened at **$16.57**. The company boasts a market capitalization of **$1.97 billion**, with a price-to-earnings (P/E) ratio of **-38.53** and a price/earnings to growth (PEG) ratio of **0.60**. The stock has a beta of **1.33**, indicating higher volatility compared to the market. Over the past fifty days, the stock has maintained a simple moving average of **$22.61**, while the 200-day moving average stands at **$26.18**. The company’s financial ratios reveal a current ratio of **1.15**, a quick ratio of **1.15**, and a debt-to-equity ratio of **1.45**. Over the last twelve months, the stock has recorded a low of **$15.88** and a high of **$47.15**.
In related news, insider **James Morgan Roche** sold **80,000 shares** of Baldwin Insurance Group on **December 15**, at an average price of **$24.03** per share, resulting in a total transaction value of **$1,922,400**. Following this sale, Roche holds **42,113 shares**, valued at approximately **$1,011,975**. This transaction represents a **65.51%** reduction in Roche’s holdings. The sale was reported to the **Securities and Exchange Commission** and is publicly accessible via their website. In the past ninety days, insiders have sold a total of **255,000 shares** valued at **$6.12 million**, with insiders collectively owning **20.14%** of the company.
Analyst Ratings and Price Targets
Baldwin Insurance Group has garnered attention from various analysts, resulting in several adjustments to its price targets. **BMO Capital Markets** recently lowered its price objective from **$34.00** to **$33.00**, maintaining a “market perform” rating as of **December 4**. **Weiss Ratings** reiterated a “sell (e+)” rating on the company’s shares in their report dated **December 29**. Meanwhile, **UBS Group** adjusted its price target from **$52.00** to **$47.00**, issuing a “buy” rating on **November 10**. **JPMorgan Chase & Co.** has also revised their price objective, decreasing it from **$33.00** to **$28.00** and assigning a “neutral” rating as of **January 7**. In another report, **Jefferies Financial Group** reaffirmed a “hold” rating with a target price of **$28.00** on **December 15**.
Currently, two analysts recommend a “buy” rating, four maintain a “hold” rating, and two analysts have issued a “sell” rating. According to data from **MarketBeat.com**, the consensus rating for Baldwin Insurance Group is “hold,” with an average price target of **$33.83**.
About Baldwin Insurance Group
Baldwin Insurance Group, Inc. is a specialty insurance and surety firm that engages in underwriting contract bonds, commercial insurance policies, and related risk management services. Its primary offerings include contract and commercial surety, which provide performance and payment guarantees for construction, service, and public sector projects. The company also provides complementary commercial lines designed to mitigate liability, property, and workers’ compensation risks.
Baldwin Insurance Group operates through a network of regional agency offices primarily located in the Midwestern United States, serving contractors, developers, small to mid-sized businesses, and municipal clients. As the company prepares for its earnings announcement, stakeholders will be keenly watching for insights into its financial health and future outlook.
